The mode, intensity (resistance) and duration of each strength exercise were based on the results of the participant's baseline physical function testing.
The duration of the strength and aerobic fitness protocol was similar (~ 20 min), and the order of the protocols was randomized to control for a possible order effect.
Post-hoc analyses for subgroups defined by gender, BMI, waist circumference, duration of hypertension, strength of antihypertensive response, and previous and concomitant antihypertensive treatment, respectively, were carried out.
The coefficients α (basal value of call duration), β (strength of the dependence of the duration of the succeeding call on the logarithm of the inter-call gap) and (beta') (strength of the dependence, when both the duration and the gap are scaled by their respective averages) resulting from regression fits when pairs in (mathcal{S}) (set of regular contacts) are categorized into different subsets.
Secondary outcomes included: duration of sick leave, strength, pain, cosmetic outcome, implant failure, infection rate, throwing ability, loss of reduction of anatomical position, ossification of the coracoclavicular ligament, range of motion, and the incidence of acromioclavicular joint osteoarthritis (OA).
To evaluate duration of oestrus and strength of expression, the visual oestrus detection was performed in a standardised manner using a scoring scale (Table 1), modified from van Eerdenburg et al. [ 22].
Additionally, the correlation coefficients were calculated between lateral trunk motion and knee pain and gender, age, stiffness (WOMAC), maximum walking speed, body mass index (BMI), duration of complaints, muscle strength and disease severity (K&L grade).
Regression analyses were repeated with adjustment for gender, age, stiffness (WOMAC), maximum walking speed, body mass index (BMI), duration of complaints, muscle strength and disease severity (K&L grade).
For some gene therapy applications, it would be desirable to be able to control the duration and strength of the expression of the therapeutic gene, using clinically relevant approaches, which are now being developed.
